ENTRY       D02745                      Drug
NAME        Interferon alfa-2b (USAN);
            Interferon alfa-2b (genetical recombination) (JAN);
            Intron A (TN)
PRODUCT     INTRON A (Merck Sharp & Dohme LLC)
FORMULA     C860H1353N229O255S9
EXACT_MASS  19256.7431
MOL_WEIGHT  19268.9111
SEQUENCE    CDLPQTHSLG SRRTLMLLAQ MRRISLFSCL KDRHDFGFPQ EEFGNQFQKA ETIPVLHEMI
            QQIFNLFSTK DSSAAWDETL LDKFYTELYQ QLNDLEACVI QGVGVTETPL MKEDSILAVR
            KYFQRITLYL KEKKYSPCAW EVVRAEIMRS FSLSTNLQES LRSKE
  TYPE      Peptide
CLASS       Immunological agent
             DG01752  Interferone
REMARK      ATC code: L03AB05
            Chemical structure group: DG01750
            Product (DG01750): D02745<US> D03305<JP>
EFFICACY    Antineoplastic, Antiviral, Biological response modifier
  DISEASE   Hairy cell leukemia [DS:H00006]
            Malignant melanoma [DS:H00038]
            Follicular lymphoma [DS:H01613]
            Condylomata acuminata [DS:H01418]
            AIDS-related Kaposi's sarcoma [DS:H00041]
            Chronic hepatitis C [DS:H00413]
            Chronic hepatitis B [DS:H00412]
TARGET      IFNAR1 [HSA:3454] [KO:K05130]
            IFNAR2 [HSA:3455] [KO:K05131]
  PATHWAY   hsa04060(3454+3455)  Cytokine-cytokine receptor interaction
            hsa04620(3454+3455)  Toll-like receptor signaling pathway
            hsa04630(3454+3455)  JAK-STAT signaling pathway
            hsa04650(3454+3455)  Natural killer cell mediated cytotoxicity
            hsa05160(3454+3455)  Hepatitis C
            hsa05161(3454)  Hepatitis B
            hsa05167(3454+3455)  Kaposi sarcoma-associated herpesvirus infection
            hsa05200(3454+3455)  Pathways in cancer
INTERACTION  
STR_MAP     map07044  Antiviral agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L03 IMMUNOSTIMULANTS
               L03A IMMUNOSTIMULANTS
                L03AB Interferons
                 L03AB05 Interferon alfa-2b
                  D02745  Interferon alfa-2b (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Immunostimulants
               Interferons
                Interferon Alfa 2b
                 D02745  Interferon alfa-2b (USAN)
            Drug groups [BR:br08330]
             Immunological agent
              DG01752  Interferone
               DG01750  Interferon alpha
                D02745  Interferon alfa-2b
            Drug classes [BR:br08332]
             Immunological agent
              DG01752  Interferone
               D02745  Interferon alfa-2b
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interferon receptors
                IFNAR1
                 D02745  Interferon alfa-2b (USAN) &lt;US&gt;
                IFNAR2
                 D02745  Interferon alfa-2b (USAN) &lt;US&gt;
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Interferon
                D02745  Interferon alfa-2b (USAN) &lt;US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02745
            Drug groups [BR:br08330]
             Immunological agent
              DG01752  Interferone
               DG01750  Interferon alpha
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Interferon
                DG01750  Interferon alpha
DBLINKS     CAS: 99210-65-8
            PubChem: 47205818
///
